Researchers are seeking alternatives to the systematic biopsy in men flagged by PSA screening. One option is to start with a magnetic resonance imaging (MRI) scan of the prostate, and then focus the ...
Business Highlights Q3-2024 revenue growth of 64% over Q3-2023. Profound continued to see a wide variety of prostate disease patients treated by its TULSA-PRO ® customers in the third quarter of 2024: ...